GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma
Introduction: Lenvatinib has recently become available as the first-line therapy for advanced hepatocellular carcinoma (HCC), but its molecular mechanism in HCC remains largely unknown. Objectives: The current study aims to identify the molecular mechanisms of lenvatinib in HCC. Methods: Gene expres...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2023-02-01
|
| Collection: | Journal of Advanced Research |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S2090123222000741 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|